Company intelligence / Profile preview

Minafin Group

Mont-Saint-Guilbert, Walloon Brabant, Belgiumminafin.com ↗

Ownership: Private
Employees: ~900
Development stage: Commercial

Overview

Minafin does not conduct its own clinical trials but provides custom manufacturing of APIs/HPAPIs/intermediates used in approved and investigational drugs. It has significant expertise in process development and scale-up for pharma clients globally. Its Minakem unit supplies both patented/generic APIs including those used in oncology and anti-infective therapies. No direct clinical results as it does not sponsor trials.

Therapeutic areas: OtherOncologyDermatologyInfectious Diseases
Modalities: Small moleculeHigh-potent active pharmaceutical ingredients (HPAPIs)Biologic (chemical synthesis support)Green chemistry products
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Minafin Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Minafin Group.

Explore the full profile